Compared to Estimates, Avantor (AVTR) Q1 Earnings: A Look at Key Metrics

Avantor, Inc. (AVTR) reported $1.58 billion in revenue for the quarter ended March 2025, representing a year-over-year decline of 5.9%. EPS of $0.23 for the same period compares to $0.22 a year ago.The reported revenue represents a surprise of -1.72% over the Zacks Consensus Estimate of $1.61 billion. With the consensus EPS estimate being $0.23, the company has not delivered EPS surprise.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Avantor performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenue- Bioscience Production: $516.40 million versus the four-analyst average estimate of $530.71 million. Revenue- Laboratory Solutions: $1.07 billion compared to the $1.09 billion average estimate based on four analysts. Adjusted Operating Income- Laboratory Solutions: $139 million versus $128.24 million estimated by two analysts on average. Adjusted Operating Income- Corporate: -$19.60 million compared to the -$14.91 million average estimate based on two analysts. Adjusted Operating Income- Bioscience Production: $123.40 million compared to the $121.23 million average estimate based on two analysts. View all Key Company Metrics for Avantor here>>>Shares of Avantor have returned -4.1% over the past month versus the Zacks S&P 500 composite's -4.8% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Avantor, Inc. (AVTR): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks